Liver Cancer Trial, Recruiting (NCT06024837)

Liver Cancer Trial, Recruiting NCT06024837 Sponsor: Centre Hospitalier Universitaire de Saint Etienne Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06024837 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with colorectal cancer that has spread to the liver and/or the lining of the abdomen (peritoneum)
Your doctors have a plan to perform surgery with the goal of fully removing the cancer

Who may not be able to join:

Your colorectal cancer has not spread to other parts of the body (no metastases)
You are receiving chemotherapy but there are no plans for surgery
Your colorectal cancer has spread only to other areas such as the lungs or bones, but not to the liver or the lining of the abdomen

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06024837

Sponsor: Centre Hospitalier Universitaire de Saint Etienne

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

More information: https://clinicaltrials.gov/study/NCT06024837

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with colorectal cancer that has spread to the liver and/or the lining of the abdomen (peritoneum)
Your doctors have a plan to perform surgery with the goal of fully removing the cancer

Who may not be able to join:

Your colorectal cancer has not spread to other parts of the body (no metastases)
You are receiving chemotherapy but there are no plans for surgery
Your colorectal cancer has spread only to other areas such as the lungs or bones, but not to the liver or the lining of the abdomen

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Registry

ClinicalTrials.gov

Start date

7 June 2023

Est. completion

1 January 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Comparison of peritoneal lesion mapping between spectral scanning and conventional scanning; Comparison of hepatic lesion mapping between spectral scanning and conventional scanning

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov